Fraud Alert

Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails
and websites falsely offering employment opportunities in our name.

We never request payment from applicants. If you receive suspicious communications claiming
to represent our company, please contact us directly to verify authenticity.

Manténgase sano!

  • Posted June 23, 2025

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

El servicio de noticias de salud es un servicio para los usuarios de la página web de Gateway Pharmacy gracias a HealthDay. Gateway Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.
Derechos de autor © 2026 HealthDay Reservados todos los derechos.

Compartir

Etiquetas